Blue Ocean Equities

Blue Ocean Equities

Financial Services

Sydney, NSW 1,945 followers

About us

In a relatively short space of time Blue Ocean Equities has emerged as a unique financial services offering in the Australian and international marketplace. Blue Ocean was formed in 2012 by the founders and a number of former directors of Southern Cross Equities who identified a niche in the market. From inception their aim was to create an independent, Australian owned, client focused, full service advisory and securities & equities dealing firm. Blue Ocean’s point of difference lies in the ability to combine our ideas driven approach, with the execution capacity comparable to that of the major global stockbroking houses. We provide our services to a combination of wholesale and high net worth investors and corporate clients. Settlement and clearing services are provided through Pershing Securities Australia, whose parent company, The Bank of New York Mellon Corporation, is one of the world’s largest equity clearing focused banks.

Industry
Financial Services
Company size
11-50 employees
Headquarters
Sydney, NSW
Type
Privately Held
Founded
2012
Specialties
Corporate Advisory, Research, Financial Advisory, and Financial Services

Locations

Employees at Blue Ocean Equities

Updates

  • View organization page for Blue Ocean Equities, graphic

    1,945 followers

    Blue Ocean is pleased to have acted as Joint Lead Manager in the $5.0 million Equity Raising for Anson Resources (ASN.ASX). Proceeds will be used for the rapid development of Green River, Pilot Plant operations, delivery of qualification samples to off takers and further drilling at Green River. Funds will also be applied for exploration at the Company’s Yellow Cat Uranium Project in the USA and critical minerals exploration in Australia.

    • No alternative text description for this image
  • View organization page for Blue Ocean Equities, graphic

    1,945 followers

    Blue Ocean are delighted to have acted as Joint Lead Manager for Hancock & Gore's $18.5M Placement. The funds raised through the Placement will be utilised to satisfy the upfront cash consideration for the acquisition of UK-based Schoolblazer Limited, transaction and Placement costs, and to enhance the company's balance sheet, providing increased financial flexibility for growth.

    • No alternative text description for this image
  • View organization page for Blue Ocean Equities, graphic

    1,945 followers

    Blue Ocean is pleased to have acted as Lead Manager in the $3.2 million Equity Raising for PolarX Limited (ASX:PXX). Proceeds will be used for additional drilling at the Caribou Dome deposit (7.2Mt @ 3.1% Cu) in Alaska, and to evaluate several recently identified targets in the Caribou Region as well as the nearby, undrilled Senator prospect. The Company also intends to update the mineral resource estimate and Scoping Study at the Alaska Range Project over the coming months. Proceeds may additionally be used for drilling significant gold-silver prospects at Humboldt Range (Nevada).

    • No alternative text description for this image
  • View organization page for Blue Ocean Equities, graphic

    1,945 followers

    Blue Ocean is pleased to have acted as Joint Lead Manager in the $18.0 million initial public offering of Alfabs Australia Ltd. The IPO follows a $12.0 million pre-IPO raise undertaken earlier in the year with Blue Ocean acting as lead manager. The Company will start trading on the ASX at 11AM on the 28th of June under the ticker AAL.ASX. Alfabs is a market leading diversified group of companies with core competencies in underground coal mining equipment hire, repair, overhaul and mining consumable supply together with our engineering division which undertakes heavy and complex steel fabrication, abrasive blasting, protective coatings and onsite installation, maintenance and logistics.

    • No alternative text description for this image
  • View organization page for Blue Ocean Equities, graphic

    1,945 followers

    Blue Ocean is pleased to have acted as Joint Lead Manager in the $10.0 million equity raising for Neurotech International Ltd (ASX:NTI). Capital raised to be used to accelerate registration-directed activities, fund further clinical trials as required and manufacturing expansion. Full results of the Phase I/II Rett Syndrome clinical trial including secondary endpoint analysis and safety/tolerability data expected in 2-4 weeks.

    • No alternative text description for this image

Similar pages

Browse jobs